Showing results (21-30 of 127) with videos related to
Sort By:
Pageof 13
Frontiers in Pharmacology|August 30, 2021
Cannabidiol Induces Apoptosis and Perturbs Mitochondrial Function in Human and Canine Glioma CellsChase Gross, Dominique A Ramirez, Stephanie McGrath, et al.Cancer Chemotherapy and Pharmacology|March 30, 2007
Dose scheduling of the dual VEGFR and EGFR tyrosine kinase inhibitor vandetanib (ZD6474, Zactima) in combination with radiotherapy in EGFR-positive and EGFR-null human head and neck tumor xenograftsDaniel L Gustafson, Barbara Frederick, Andrea L Merz, et al.Veterinary and Comparative Oncology|January 15, 2019
Doxorubicin area under the curve is an important predictor of neutropenia in dogs with naturally occurring cancersLuke A Wittenburg, Kristen Weishaar, Dominique Ramirez, et al.Journal of Veterinary Pharmacology and Therapeutics|December 8, 2020
Pharmacokinetics of a sulfadiazine and trimethoprim suspension in neonatal foalsElsbeth Swain O'Fallon, Patrick McCue, Sangeeta Rao, et al.BMC Medical Genomics|June 19, 2019
A systematic analysis of genomics-based modeling approaches for prediction of drug response to cytotoxic chemotherapiesJoshua D Mannheimer, Dawn L Duval, Ashok Prasad, et al.Assay and Drug Development Technologies|December 23, 2015
Drug Selection in the Genomic Age: Application of the Coexpression Extrapolation Principle for Drug Repositioning in Cancer TherapyDaniel L Gustafson, Jared S Fowles, Kristen C Brown, et al.Journal of Pharmaceutical Sciences|July 13, 2002
Doxorubicin pharmacokinetics: Macromolecule binding, metabolism, and excretion in the context of a physiologic modelDaniel L Gustafson, Jeffrey C Rastatter, Tina Colombo, et al.Cancer Chemotherapy and Pharmacology|July 28, 2009
Population pharmacokinetic model of PI-88, a heparanase inhibitorSusan F Hudachek, S Gail Eckhardt, Barbara Hicks, et al.Toxicology Research|April 24, 2024
Comparative safety, pharmacokinetics, and off-target assessment of 1,1-bis(3'-indolyl)-1-(p-chlorophenyl) methane in mouse and dog: implications for therapeutic developmentSavannah M Rocha, Daniel L Gustafson, Stephen Safe, et al.Journal of Equine Veterinary Science|March 21, 2022
Pharmacokinetics, Safety, and Synovial Fluid Concentrations of Single- and Multiple-Dose Oral Administration of 1 and 3 mg/kg Cannabidiol in HorsesAlicia F Yocom, Elsbeth S O'Fallon, Daniel L Gustafson, et al.Pageof 13